Viberzi and Proair hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viberzi (eluxadoline) and Proair hfa (albuterol sulfate). Common drug interactions include pain among females and ammonia increased among males.

The phase IV clinical study analyzes what interactions people have when they take Viberzi and Proair hfa. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Viberzi?

Viberzi has active ingredients of eluxadoline. eHealthMe is studying from 3,077 Viberzi users. Check the latest studies of Viberzi.

What is Proair hfa?

Proair hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 53,227 Proair hfa users. Check the latest studies of Proair hfa.



On Jul, 15, 2026

42 people who take Viberzi and Proair hfa together, and have interactions are studied.

Viberzi and Proair hfa drug interactions.

What are the common drug interactions of Viberzi and Proair Hfa, by gender? *:

female:

  1. Pain
  2. Headache (pain in head)
  3. Nausea (feeling of having an urge to vomit)
  4. Vomiting
  5. Diarrhoea
  6. Foot fracture
  7. Abdominal pain upper
  8. Ankle fracture
  9. Arthralgia (joint pain)
  10. Asthenia (weakness)

male:

  1. Ammonia increased
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Local reaction (reaction of any substance at the site of use)
  4. Obesity (having too much body fat)
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Osteoporosis (bones weak and more likely to break)
  7. Pain
  8. Platelet count decreased
  9. Renal failure (kidney dysfunction)
  10. Type 2 diabetes mellitus

What are the common drug interactions of Viberzi and Proair Hfa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pancreatitis acute (sudden inflammation of pancreas)
  2. Anxiety
  3. Depressed mood
  4. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  5. Pain
  6. Diarrhoea
  7. Hepatic enzyme increased
  8. Hyperbilirubinaemia (excess of bilirubin in the blood)
  9. Leukocytosis (increased white blood cells)

30-39:

n/a

40-49:

  1. Injection site extravasation (flow of (blood or lymph) from injection site)
  2. Injection site nerve damage
  3. Limb discomfort (discomfort in leg)
  4. Pain in extremity
  5. Psoriasis (immune-mediated disease that affects the skin)

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhoea
  3. Vomiting
  4. Abdominal pain upper
  5. Pancreatitis (inflammation of pancreas)
  6. Back pain
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Fatigue (feeling of tiredness)
  9. Headache (pain in head)
  10. Infusion related reaction

60+:

  1. Pain
  2. Ankle fracture
  3. Oedema peripheral (superficial swelling)
  4. Confusional state
  5. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  6. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Heart rate irregular
  10. Hypertension (high blood pressure)

What are the existing conditions these people have? *

  1. Irritable Bowel Syndrome: 9 people, 21.43%
  2. Immunodeficiency Common Variable: 6 people, 14.29%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 5 people, 11.90%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 11.90%
  5. Migraine (headache): 5 people, 11.90%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 11.90%
  7. High Blood Pressure: 4 people, 9.52%
  8. Diarrhea: 4 people, 9.52%
  9. Stress And Anxiety: 3 people, 7.14%
  10. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Viberzi and Proair hfa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Viberzi and Proair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Viberzi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Proair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viberzi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proair hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eluxadoline and albuterol sulfate (the active ingredients of Viberzi and Proair hfa, respectively), and Viberzi and Proair hfa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: